Go Pro

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AXLA

Axcella Health (AXLA) Stock Price, News & Analysis

Axcella Health logo

About Axcella Health Stock (NASDAQ:AXLA)

Key Stats

Today's Range
$0.40
$0.40
50-Day Range
$0.40
$4.58
52-Week Range
$0.34
$41.25
Volume
N/A
Average Volume
267,009 shs
Market Capitalization
$1.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Axcella Health Inc. operates as a clinical-stage biotechnology company in the United States. The company treats complex diseases using endogenous metabolic modulators. Its product pipeline includes AXA1125 that is in Phase 2a clinical trial for long COVID therapy for patients, as well as Phase 2b clinical trial for treating non-alcoholic steatohepatitis; and AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

Receive AXLA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Axcella Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AXLA Stock News Headlines

A $5 stock inside Kennedy Space Center?
A small publicly traded company operates a specialized launch vehicle fleet inside the secure perimeter of Kennedy Space Center, just steps from SpaceX and Blue Origin. Under a special operating agreement, the company uses the multi-billion-dollar federal facility for just 500 dollars. Its launch system reportedly cuts fuel costs by 90 percent and enables multiple launches in a single day. The stock currently trades under 5 dollars and is approaching a key licensing milestone most retail investors have not yet noticed.tc pixel
Axcella Health to close
Axcella Health Inc AXLA
Pre-market Movers: RLMD, BROG, VSME, AXLA, NKE…
See More Headlines

AXLA Stock Analysis - Frequently Asked Questions

Axcella Health Inc. (NASDAQ:AXLA) posted its earnings results on Wednesday, November, 10th. The company reported ($10.25) EPS for the quarter, topping the consensus estimate of ($11.25) by $1.00.

Shares of Axcella Health reverse split before market open on Tuesday, September 19th 2023.The 1-25 reverse split was announced on Thursday, September 14th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, September 18th 2023. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

Axcella Health (AXLA) raised $76 million in an initial public offering (IPO) on Thursday, May 9th 2019. The company issued 3,600,000 shares at $20.00-$22.00 per share. Goldman Sachs, J.P. Morgan and SVB Leerink acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Axcella Health investors own include Predictive Oncology (POAI), Meta Platforms (META), NVIDIA (NVDA), Ford Motor (F), JPMorgan Chase & Co. (JPM) and Abbott Laboratories (ABT).

Company Calendar

Last Earnings
11/10/2021
Today
8/09/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:AXLA
CIK
1633070
Employees
11
Year Founded
2010

Profitability

EPS (Trailing Twelve Months)
($19.25)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$81.19 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-259.91%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.80
Quick Ratio
0.80

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.42 per share
Price / Book
0.28

Miscellaneous

Outstanding Shares
2,950,000
Free Float
2,883,000
Market Cap
$1.18 million
Optionable
No Data
Beta
0.46

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NASDAQ:AXLA) was last updated on 8/10/2026 by MarketBeat.com Staff.
From Our Partners